These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35668465)

  • 1. Towards elimination of Lymphatic Filariasis in Kenya: improving advocacy, communication and social mobilization activities for mass drug administration, a qualitative study.
    Kibe LW; Kimani BW; Okoyo C; Omondi WP; Sultani HM; Njomo DW
    Trop Dis Travel Med Vaccines; 2022 Jun; 8(1):16. PubMed ID: 35668465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fight against lymphatic filariasis: perceptions of community drug distributors during mass drug administration in coastal Kenya.
    Kusi C; Steinmann P; Merten S
    Infect Dis Poverty; 2020 Mar; 9(1):22. PubMed ID: 32114985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation challenges and opportunities for improved mass treatment uptake for lymphatic filariasis elimination: Perceptions and experiences of community drug distributors of coastal Kenya.
    Njomo DW; Kimani BW; Kibe LW; Okoyo C; Omondi WP; Sultani HM
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0009012. PubMed ID: 33370300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing barriers of community participation and access to mass drug administration for lymphatic filariasis elimination in Coastal Kenya using a participatory approach.
    Njomo DW; Kibe LW; Kimani BW; Okoyo C; Omondi WP; Sultani HM
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008499. PubMed ID: 32936792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing coverage in mass drug administration for lymphatic filariasis elimination in an urban setting: a study of Malindi Town, Kenya.
    Njomo DW; Mukoko DA; Nyamongo NK; Karanja J
    PLoS One; 2014; 9(1):e83413. PubMed ID: 24454703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 6th Meeting of the Global Alliance to Eliminate Lymphatic Filariasis: A half-time review of lymphatic filariasis elimination and its integration with the control of other neglected tropical diseases.
    Addiss D;
    Parasit Vectors; 2010 Oct; 3():100. PubMed ID: 20961435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community views on mass drug administration for filariasis: a qualitative evidence synthesis.
    Taylor M; Thomas R; Oliver S; Garner P
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD013638. PubMed ID: 35174482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving drug delivery strategies for lymphatic filariasis elimination in urban areas in Ghana.
    Biritwum NK; Garshong B; Alomatu B; de Souza DK; Gyapong M; Kyelem D
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005619. PubMed ID: 28493966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa.
    Silumbwe A; Zulu JM; Halwindi H; Jacobs C; Zgambo J; Dambe R; Chola M; Chongwe G; Michelo C
    BMC Public Health; 2017 May; 17(1):484. PubMed ID: 28532397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementer and recipient perspectives of community-wide mass drug administration for soil-transmitted helminths in Kwale County, Kenya.
    Legge H; Kepha S; Prochazka M; Halliday K; Pullan R; Gwayi-Chore MC; Njomo D
    PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008258. PubMed ID: 32310966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How community engagement strategies shape participation in mass drug administration programmes for lymphatic filariasis: The case of Luangwa District, Zambia.
    Silumbwe A; Halwindi H; Zulu JM
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007861. PubMed ID: 31774820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatic filariasis in Fiji: progress towards elimination, 1997-2007.
    Manolas RK; Kama M; Rainima-Qaniuci M; Bechu VD; Tuibeqa S; Winston MV; Ram N; Naqio F; Ichimori K; Capuano C; Ozaki M; Kim SH; Aratchige P; Sahukhan A; Graves PM
    Trop Med Health; 2020; 48():88. PubMed ID: 33132735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997-2006.
    Allen T; Taleo F; Graves PM; Wood P; Taleo G; Baker MC; Bradley M; Ichimori K
    Trop Med Health; 2017; 45():8. PubMed ID: 28579911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid ethnography and participatory techniques increase onchocerciasis mass drug administration treatment coverage in Benin: a difference-in-differences analysis.
    Means AR; Sambiéni NE; Avokpaho E; Monra AB; Kpatinvoh FAE; Bardosh K; Ibikounlé M
    Implement Sci Commun; 2023 Apr; 4(1):45. PubMed ID: 37101244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community perspectives on persistent transmission of lymphatic filariasis in three hotspot districts in Ghana after 15 rounds of mass drug administration: a qualitative assessment.
    Ahorlu CSK; Koka E; Adu-Amankwah S; Otchere J; de Souza DK
    BMC Public Health; 2018 Feb; 18(1):238. PubMed ID: 29433461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of lymphatic filariasis: current perspectives on mass drug administration.
    Gyapong JO; Owusu IO; da-Costa Vroom FB; Mensah EO; Gyapong M
    Res Rep Trop Med; 2018; 9():25-33. PubMed ID: 30050352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experiences and perspectives of community health workers from implementing treatment for schistosomiasis using the community directed intervention strategy in an informal settlement in Kisumu City, western Kenya.
    Odhiambo GO; Musuva RM; Odiere MR; Mwinzi PN
    BMC Public Health; 2016 Sep; 16():986. PubMed ID: 27634152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing implementation of mass drug administration for lymphatic filariasis elimination: a mixed-method study in Odisha, India.
    Ratna P; Sinha A; Pati S; Sahoo PK
    Front Pharmacol; 2024; 15():1297954. PubMed ID: 38414733
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines.
    Amarillo ML; Belizario VY; Sadiang-Abay JT; Sison SA; Dayag AM
    Parasit Vectors; 2008 May; 1(1):14. PubMed ID: 18505577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintaining effective mass drug administration for lymphatic filariasis through in-process monitoring in Sierra Leone.
    Hodges MH; Sonnie M; Turay H; Conteh A; Maccarthy F; Sesay S
    Parasit Vectors; 2012 Oct; 5():232. PubMed ID: 23062561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.